{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T04:49:06Z","timestamp":1769748546955,"version":"3.49.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,17]],"date-time":"2023-12-17T00:00:00Z","timestamp":1702771200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIGMS","doi-asserted-by":"publisher","award":["1R43GM149009-01"],"award-info":[{"award-number":["1R43GM149009-01"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIGMS","doi-asserted-by":"publisher","award":["1R44GM148998-01"],"award-info":[{"award-number":["1R44GM148998-01"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIGMS","doi-asserted-by":"publisher","award":["1R43GM146473-01"],"award-info":[{"award-number":["1R43GM146473-01"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","award":["1R44AI177126-01"],"award-info":[{"award-number":["1R44AI177126-01"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008510","name":"University of Maryland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008510","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["New Biotechnology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.nbt.2023.12.004","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T21:39:46Z","timestamp":1703021986000},"page":"27-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Site-directed neutralizing antibodies targeting structural sites on SARS-CoV-2 spike protein"],"prefix":"10.1016","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-3765-0124","authenticated-orcid":false,"given":"Xiaofeng","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liudmila","family":"Kulakova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kezzia","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric A.","family":"Toth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina Kirkland","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiana","family":"Mendez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas R.","family":"Fuerst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbt.2023.12.004_bib1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jim.2017.05.010","article-title":"A method for the isolation and characterization of functional murine monoclonal antibodies by single B cell cloning","volume":"448","author":"Carbonetti","year":"2017","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.nbt.2023.12.004_bib2","article-title":"Development of neutralizing antibodies against SARS-CoV-2, using a high-throughput single-B-cell cloning method","volume":"6","author":"Dou","year":"2023","journal-title":"Antib Ther"},{"key":"10.1016\/j.nbt.2023.12.004_bib3","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2021.2002236","article-title":"Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage libraries","volume":"14","author":"Yuan","year":"2022","journal-title":"MAbs"},{"key":"10.1016\/j.nbt.2023.12.004_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-21609-2","article-title":"SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface","volume":"12","author":"Bertoglio","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.nbt.2023.12.004_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202102181","article-title":"Neutralizing Antibodies to SARS-CoV-2 Selected from a Human Antibody Library Constructed Decades Ago","volume":"9","author":"Qiang","year":"2022","journal-title":"Adv Sci"},{"key":"10.1016\/j.nbt.2023.12.004_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/s41577-022-00784-3","article-title":"Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses","volume":"23","author":"Chen","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.nbt.2023.12.004_bib7","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1146\/annurev-immunol-032712-095916","article-title":"Broadly neutralizing antiviral antibodies","volume":"31","author":"Corti","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.nbt.2023.12.004_bib8","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s13238-018-0534-7","article-title":"The development of HIV vaccines targeting gp41 membrane-proximal external region (MPER): challenges and prospects","volume":"9","author":"Liu","year":"2018","journal-title":"Protein Cell"},{"key":"10.1016\/j.nbt.2023.12.004_bib9","first-page":"162","article-title":"SARS-CoV-2 variant biology: immune escape, transmission and fitness","volume":"21","author":"Carabelli","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.nbt.2023.12.004_bib10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1084\/jem.20121977","article-title":"Identification of autoantigens recognized by the 2F5 and 4E10 broadly neutralizing HIV-1 antibodies","volume":"210","author":"Yang","year":"2013","journal-title":"J Exp Med"},{"key":"10.1016\/j.nbt.2023.12.004_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-96233-7","article-title":"Homology between SARS CoV-2 and human proteins","volume":"11","author":"Khavinson","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.nbt.2023.12.004_bib12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/j.1460-2075.1985.tb03635.x","article-title":"Somatic mutation and clonal expansion of B cells in an antigen-driven immune response","volume":"4","author":"Sablitzky","year":"1985","journal-title":"EMBO J"},{"key":"10.1016\/j.nbt.2023.12.004_bib13","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev.immunol.14.1.441","article-title":"Somatic hypermutation of immunoglobulin genes","volume":"14","author":"Wagner","year":"1996","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.nbt.2023.12.004_bib14","doi-asserted-by":"crossref","first-page":"14889","DOI":"10.1073\/pnas.0604045103","article-title":"Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy","volume":"103","author":"Zarling","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nbt.2023.12.004_bib15","doi-asserted-by":"crossref","first-page":"12821","DOI":"10.1073\/pnas.1110042108","article-title":"Loss of CD4 T-cell-dependent tolerance to proteins with modified amino acids","volume":"108","author":"Gauba","year":"2011","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.nbt.2023.12.004_bib16","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1471-4906(01)01976-7","article-title":"Post-translational protein modifications in antigen recognition and autoimmunity","volume":"22","author":"Doyle","year":"2001","journal-title":"Trends Immunol"},{"key":"10.1016\/j.nbt.2023.12.004_bib17","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.cell.2021.12.032","article-title":"The Omicron variant is highly resistant against antibody-mediated neutralization: implications for control of the COVID-19 pandemic","volume":"185","author":"Hoffmann","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.nbt.2023.12.004_bib18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cell.2021.12.033","article-title":"mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant","volume":"185","author":"Garcia-Beltran","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.nbt.2023.12.004_bib19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.cell.2022.01.006","article-title":"Omicron\u2019s message on vaccines: boosting begets breadth","volume":"185","author":"Wesemann","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.nbt.2023.12.004_bib20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cell.2021.12.046","article-title":"SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses","volume":"185","author":"Dejnirattisai","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.nbt.2023.12.004_bib21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri724","article-title":"Epitope spreading in immune-mediated diseases: implications for immunotherapy","volume":"2","author":"Vanderlugt","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.nbt.2023.12.004_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.immunol.19.1.1","article-title":"Specificity and degeneracy in antigen recognition: yin and yang in the immune system","volume":"19","author":"Eisen","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.nbt.2023.12.004_bib23","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","article-title":"Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19","volume":"41","author":"Huang","year":"2020","journal-title":"Acta Pharm Sin"},{"key":"10.1016\/j.nbt.2023.12.004_bib24","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41423-020-0400-4","article-title":"Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine","volume":"17","author":"Tai","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.nbt.2023.12.004_bib25","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/imr.13084","article-title":"Protective neutralizing epitopes in SARS-CoV-2","volume":"310","author":"Liu","year":"2022","journal-title":"Immunol Rev"},{"key":"10.1016\/j.nbt.2023.12.004_bib26","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41586-020-2852-1","article-title":"SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies","volume":"588","author":"Barnes","year":"2020","journal-title":"Nature"},{"issue":"1979","key":"10.1016\/j.nbt.2023.12.004_bib27","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.abc7520","article-title":"Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model","volume":"369","author":"Rogers","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.nbt.2023.12.004_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2021.03.028","article-title":"N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2","volume":"184","author":"McCallum","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.nbt.2023.12.004_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109928","article-title":"Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain","volume":"37","author":"Cerutti","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.nbt.2023.12.004_bib30","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1126\/science.abj3321","article-title":"Broad betacoronavirus neutralization by a stem helix\u2013specific human antibody","volume":"373","author":"Pinto","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.nbt.2023.12.004_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/s41564-022-01155-3","article-title":"Neutralization mechanism of a human antibody with pan-coronavirus reactivity including SARS-CoV-2","volume":"7","author":"Sun","year":"2022","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.nbt.2023.12.004_bib32","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/s41586-022-04581-9","article-title":"Molecular basis of receptor binding and antibody neutralization of Omicron","volume":"604","author":"Hong","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.nbt.2023.12.004_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12998\/wjcc.v10.i1.1","article-title":"Omicron variant (B.1.1.529) of SARS-CoV-2: mutation, infectivity, transmission, and vaccine resistance","volume":"10","author":"Ren","year":"2022","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.nbt.2023.12.004_bib34","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera-a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J Comput Chem"},{"issue":"1979","key":"10.1016\/j.nbt.2023.12.004_bib35","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"issue":"1979","key":"10.1016\/j.nbt.2023.12.004_bib36","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1126\/science.abd0826","article-title":"Structure-based design of prefusion-stabilized SARS-CoV-2 spikes","volume":"369","author":"Hsieh","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.nbt.2023.12.004_bib37","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0378-1119(93)90587-S","article-title":"A method for the site-directed mono- and multi-mutagenesis of double-stranded DNA","volume":"126","author":"Weiner","year":"1993","journal-title":"Gene"},{"key":"10.1016\/j.nbt.2023.12.004_bib38","first-page":"239","article-title":"Site-directed mutagenesis using a rapid PCR-based method","volume":"57","author":"Costa","year":"1996","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.nbt.2023.12.004_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1178355","article-title":"The molecular basis of the neutralization breadth of the RBD-specific antibody CoV11","volume":"14","author":"Tolbert","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.nbt.2023.12.004_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2021.03.005","article-title":"Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite","volume":"29","author":"Cerutti","year":"2021","journal-title":"Cell Host Microbe"},{"issue":"1979","key":"10.1016\/j.nbt.2023.12.004_bib41","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1126\/science.abb7269","article-title":"A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV","volume":"368","author":"Yuan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.nbt.2023.12.004_bib42","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target","volume":"46","author":"Zhang","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.nbt.2023.12.004_bib43","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bbrc.2021.11.059","article-title":"Emerging mutation patterns in SARS-CoV-2 variants","volume":"586","author":"Ostrov","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nbt.2023.12.004_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2022.112816","article-title":"Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic","volume":"209","author":"Khandia","year":"2022","journal-title":"Environ Res"},{"key":"10.1016\/j.nbt.2023.12.004_bib45","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-0716-3381-6_24","article-title":"Validation and the determination of antibody bioactivity using MILKSHAKE and sundae protocols","volume":"2702","author":"Ferguson","year":"2023","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.nbt.2023.12.004_bib46","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2144\/btn-2021-0078","article-title":"MILKSHAKE: novel validation method for antibodies to post-translationally modified targets by surrogate Western blot","volume":"72","author":"Jones","year":"2022","journal-title":"Biotechniques"},{"key":"10.1016\/j.nbt.2023.12.004_bib47","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-0716-3381-6_29","article-title":"Epivolve: a protocol for site-directed antibodies","volume":"2702","author":"Li","year":"2023","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.nbt.2023.12.004_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1222267","article-title":"Use of epivolve phage display to generate a monoclonal antibody with opsonic activity directed against a subdominant epitope on extracellular loop 4 of Treponema pallidum BamA (TP0326)","volume":"14","author":"Ferguson","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.nbt.2023.12.004_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbt.2022.06.003","article-title":"Derivation of splice junction-specific antibodies using a unique hapten targeting strategy and directed evolution","volume":"71","author":"Fuller","year":"2022","journal-title":"N Biotechnol"},{"issue":"1979","key":"10.1016\/j.nbt.2023.12.004_bib50","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"issue":"1979","key":"10.1016\/j.nbt.2023.12.004_bib51","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1126\/science.abc2241","article-title":"A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2","volume":"368","author":"Wu","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.nbt.2023.12.004_bib52","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-020-2381-y","article-title":"A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2","volume":"584","author":"Shi","year":"2020","journal-title":"Nature"},{"issue":"1979","key":"10.1016\/j.nbt.2023.12.004_bib53","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1126\/science.abc5881","article-title":"Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody","volume":"369","author":"Lv","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.nbt.2023.12.004_bib54","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/s41594-020-0480-y","article-title":"Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient","volume":"27","author":"Zhou","year":"2020","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.nbt.2023.12.004_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-19231-9","article-title":"Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation","volume":"11","author":"Hurlburt","year":"2020","journal-title":"Nat Commun"},{"issue":"1979","key":"10.1016\/j.nbt.2023.12.004_bib56","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1126\/science.abd0827","article-title":"Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail","volume":"369","author":"Hansen","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.nbt.2023.12.004_bib57","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1038\/s41596-020-0394-5","article-title":"Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay","volume":"15","author":"Nie","year":"2020","journal-title":"Nat Protoc"}],"container-title":["New Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871678423000729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871678423000729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T10:06:59Z","timestamp":1761732419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871678423000729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":57,"alternative-id":["S1871678423000729"],"URL":"https:\/\/doi.org\/10.1016\/j.nbt.2023.12.004","relation":{},"ISSN":["1871-6784"],"issn-type":[{"value":"1871-6784","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Site-directed neutralizing antibodies targeting structural sites on SARS-CoV-2 spike protein","name":"articletitle","label":"Article Title"},{"value":"New Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbt.2023.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Abbratech Inc. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}